ArticleNature communications2016

IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K/AKT-pathway hyperactivation.

Gerjon J Ikink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.